BioCentriq will be exhibiting at ISCT Vancouver 2024 with a company presentation, a poster and two panel discussions:
• “Let’s Talk Particulates: Working Towards Best Practices,” presented by Mark Broadley, VP of Operations.
• “End-to-end Automated Manufacturing of Low-seed CAR-T Cells,” presented by David Smith, Ph.D., VP of Development
• Poster in collaboration with Terumo Blood and Cell Technologies titled “Rapid Manufacture of Low-seed CAR-T Cells in a GMP-grade Hollow-fiber Bioreactor Platform” and presented by Melissa Mastro, Senior Engineer, MSAT
Join us at Booth 840, where our expert team, including Chathuranga De Silva Ph.D., Executive Director, Business Development will be ready to connect and discuss how we can support your cell therapy development projects.
Please fill out the form below to schedule a meeting with us at ISCT.